Capital solutions for every stage of growth
In collaboration with Mizuho's product specialists and Financial Sponsors team, we have led high-profile M&A and acquisition-financing deals as well as growth-stage financings. We provide clients a full suite of capabilities, including debt and equity offerings, leveraged finance, risk-focused derivative solutions, strategic advisory, corporate finance and working capital solutions.
Highlights
- #3 in Investment Grade Healthcare (Dealogic, March 2023)
Notable Transactions
- Active Bookrunner on Thermo Fisher’s $2.95 billion senior notes offering
- Active Bookrunner and Billing & Delivery Agent on Medtronic’s $2 billion senior notes offering
- Active Bookrunner on Amgen’s $24 billion senior notes offering
- Joint Bookrunner on Envista’s $500 million convertible notes offering
- Joint Bookrunner on GE HealthCare’s $2.2 billion secondary offering
Industry expertise
-
Biotech -
Pharma -
Medical Devices -
Healthcare Services -
Life Sciences Tools & Diagnostics